T1	Treatment 23 112	bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone
T2	Treatment 270 304	Psoralen plus ultraviolet A (PUVA)
T3	Treatment 591 601	PUVA alone
T4	Treatment 605 625	PUVA and bexarotene.
T5	Treatment 704 753	combined bexarotene (Targretin(Â®) ) and PUVA vs.
T6	Treatment 754 764	PUVA alone
T7	Treatment 1110 1123	received PUVA
T8	Treatment 1131 1157	received PUVA + bexarotene
T9	Treatment 1159 1168	Total UVA
T10	Treatment 1225 1233	the PUVA
T11	Treatment 1461 1480	with the PUVA-alone
T12	Treatment 1532 1544	71% for PUVA
T13	Treatment 1637 1647	months for
T14	Treatment 1742 1758	10 received PUVA
T15	Treatment 1779 1802	15 received combination
T16	Treatment 1912 1919	towards
T17	Treatment 1997 2010	compared with
T18	Treatment 2071 2078	towards
T19	Treatment 2166 2174	compared
T20	Treatment 2375 2388	trend towards
T21	Treatment 2459 2480	combination arm (PUVA
